Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar;20(3):197-208.

The Common miRNAs between Tuberculosis and Non-Small Cell Lung Cancer: A Critical Review

Mojgan Sheikhpour  1   2 , Hanie Abolfathi  1 , Morteza Karimipoor  3 , Abolfazl Movafagh  4 , Mahbubeh Shahsavani  5
Affiliations
Review

The Common miRNAs between Tuberculosis and Non-Small Cell Lung Cancer: A Critical Review

Mojgan Sheikhpour et al. Tanaffos. 2021 Mar.

Abstract

Tuberculosis (TB) and non-small cell lung cancer (NSCLC) are two major contributors to mortality and morbidity worldwide. In this regard, TB and NSCLC have similar symptoms, and TB has symptoms that are identical to malignancy; therefore, sometimes it is mistakenly diagnosed as lung cancer. Moreover, patients with active pulmonary TB are at a higher risk of dying due to lung cancer. In addition, several signaling pathways involved in TB and NSCLC have been identified. Also, the miRNAs are biological molecules shown to play essential roles in the above-mentioned diseases through targeting the signaling pathways' genes. Most of the pathways affected by miRNAs are immune responses such as autophagy and apoptosis in TB and NSCLC, respectively. Several studies have separately investigated the expression of miRNAs profile in patients with NSCLC and infectious TB. In this critical review, we attempted to gather common miRNAs between TB and NSCLC and to explain the involved-pathways, which are affected by miRNAs in both TB and NSCLC. Results of this critical review show that the expressions of miR-155, miR-146a, miR-125b, miR-30a, miR-29a, and miR-Let7 have significantly changed in TB and NSCLC. The data suggest that miRNAs expression may provide a new method for screening or differential diagnosis of NSCLC and TB.

Keywords: Expression; Non-small cell lung cancer; Tuberculosis; miRNA.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare that there is no conflict of interest.

Figures

Figure 1.
Figure 1.
The role of microRNAs in human cancers
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Farhat MR, Freschi L, Calderon R, Ioerger T, Snyder M, Meehan CJ, et al. GWAS for quantitative resistance phenotypes in Mycobacterium tuberculosis reveals resistance genes and regulatory regions. Nat Commun 2019;10(1):2128. - PMC - PubMed
    1. Awoniyi DO, Baumann R, Chegou NN, Kriel B, Jacobs R, Kidd M, et al. Detection of a combination of serum IgG and IgA antibodies against selected mycobacterial targets provides promising diagnostic signatures for active TB. Oncotarget 2017;8(23):37525–37537. - PMC - PubMed
    1. Liu Y, Xie Z, Zhou X, Li W, Zhang H, He ZG. NapM enhances the survival of Mycobacterium tuberculosis under stress and in macrophages. Commun Biol 2019;2:65. - PMC - PubMed
    1. Li J, Sun L, Xu F, Xiao J, Jiao W, Qi H, et al. Characterization of plasma proteins in children of different Mycobacterium tuberculosis infection status using label-free quantitative proteomics. Oncotarget 2017;8(61):103290–103301. - PMC - PubMed
    1. Mustafa AD, Kalyanasundram J, Sabidi S, Song AA, Abdullah M, Abdul Rahim R, et al. Recovery of recombinant Mycobacterium tuberculosis antigens fused with cell wall-anchoring motif (LysM) from inclusion bodies using nondenaturing reagent (N-laurylsarcosine). BMC Biotechnol 2019;19(1):27. - PMC - PubMed

LinkOut - more resources